FDA Guidance for Pharmaceutical Microbiology

FDA Guidance for Pharmaceutical Microbiology

The U.S. Food and Drug Administration (FDA) provides essential guidance for pharmaceutical microbiology to ensure sterility, contamination control, and product safety.

Key FDA Guidance Documents

  • Sterile Drug Products by Aseptic Processing (cGMP)
  • Container Closure Systems
  • Sterilization Process Validation
  • Microbiological Quality of Non-Sterile Products
  • Data Integrity Compliance

Sterility Assurance

  • Validated sterilization methods
  • Media fill validation
  • Sterility testing
  • Failure investigation

👉 Read Sterility Testing Guide

Environmental Monitoring

  • Viable monitoring
  • Non-viable monitoring
  • Trend analysis
  • CAPA system

👉 Environmental Monitoring SOP

Comments

Popular posts from this blog

Too Numerous To Count (TNTC) & Too Few To Count (TFTC) in Microbiology: Meaning, Limits, Calculations, and GMP Impact

Non-Viable Particle Count (NVPC) in Cleanrooms: Principles, Methods & GMP Requirements

Alert and Action Limits in Environmental Monitoring: GMP Meaning, Differences & Best Practices